MYF5 Antibody
- 
								中文名稱:MYF5兔多克隆抗體
- 
								貨號(hào):CSB-PA015287LA01HU
- 
								規(guī)格:¥440
- 
								圖片:
- 
								其他:
產(chǎn)品詳情
- 
											產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) MYF5 Polyclonal antibody
- 
											Uniprot No.:
- 
											基因名:
- 
											別名:bHLHc2 antibody; Class C basic helix loop helix protein 2 antibody; Class C basic helix-loop-helix protein 2 antibody; Myf 5 antibody; Myf-5 antibody; Myf5 antibody; MYF5_HUMAN antibody; Myogenic factor 5 antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human, Mouse, Rat
- 
											免疫原:Recombinant Human Myogenic factor 5 protein (1-255AA)
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:Non-conjugated本頁面中的產(chǎn)品,MYF5 Antibody (CSB-PA015287LA01HU),的標(biāo)記方式是Non-conjugated。對于MYF5 Antibody,我們還提供其他標(biāo)記。見下表: 
- 
											克隆類型:Polyclonal
- 
											抗體亞型:IgG
- 
											純化方式:>95%, Protein G purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:Preservative: 0.03% Proclin 300
 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:ELISA, WB
- 
											推薦稀釋比:Application Recommended Dilution WB 1:500-1:5000 
- 
											Protocols:
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
- 
											功能:Transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYOG and MYOD1, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Probable sequence specific DNA-binding protein.
- 
											基因功能參考文獻(xiàn):- Analysis of human rhabdomyosarcoma revealed that MYF5 and MYOD are mutually-exclusively expressed and each is required for sustained tumor growth. PMID: 28080960
- Pitx2c expression is reactivated, while expression of Myf5 is downregulated in human systolic heart failure as determined by qRT-PCR and Western blot analyses. PMID: 24595098
- results are the first demonstration of a myogenic conversion of human mesenchymal and endothelial cells by Myf5 PMID: 21810080
- DUX4c induces the MYF5 protein and myoblast proliferation, and has a role in facioscapulohumeral muscular dystrophy PMID: 19829708
- The myogenic basic helix-loop-helix family of transcription factors, MyoD, Myf5, myogenin, and MRF4, can each activate the muscle differentiation program. PMID: 12105204
- Mrf4 expression precedes or is contemporaneous with that of Myf5, suggesting that this transcription factor plays a hitherto unsuspected role in myogenesis PMID: 12204280
- Myogenin and myogenic differentiation factor D (MyoD) mRNAs increased (P < 0.05) in young and old, whereas myogenic factor (myf)-5 mRNA increased in young only (P < 0.05). Myf-6 protein increased (P < 0.05) in both young and old. PMID: 16614355
- A novel homozygous polymorphism that prevented the binding of MYF-5 to FOXE1 promoter and affected the FOXE1 expression was found in 45% nonsyndromic cleft palate. PMID: 19192046
 顯示更多 收起更多 
- 
											亞細(xì)胞定位:Nucleus.
- 
											數(shù)據(jù)庫鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
  
 













 
         
           
  
          